Mahadevia Ankit 4
4 · Spero Therapeutics, Inc. · Filed Sep 3, 2025
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2025-08-28$1.97/sh−6,572$12,947→ 703,294 total
Footnotes (2)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of restricted stock unit ("RSUs") that were granted to the Reporting Person on August 26, 2021.
- [F2]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.